This is an observational study that evaluate the effectiveness and safety of Korean integrative treatments in patients with peripheral facial nerve palsy. Adulthood patients aged between 19 to 69 who were diagnosed with peripheral facial nerve palsy and receive Korean integrative treatments for facial palsy will be enrolled in the study and the change will be followed according to the Facial disability index (FDI) at the 3 month moment after baseline.
age of 19 to 69
diagnosed with unilateral peripheral facial nerve palsy
onset of facial palsy within 3 weeks or less.
an individual who can provide written consent form to participate in the study.
diagnosed with central nervous system disease causing facial palsy
secondary facial palsy after multiple sclerosis, tumor, cerebrovascular disease and temporal bone fracture.
Ramsay-Hunt syndrome
bilateral or recurrent facial nerve palsy.